A
$ Value
$7K
Shares
299
Price
$24
Filed
Jul 2
Insider
Name
Gangloff Scott A.
Title
Chief Technology Officer
CIK
0001663253
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
23,751
Footnotes
Mr. Gangloff is voluntarily reporting the acquisition of these shares on June 30, 2025 pursuant to the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(c) and Rule 16b-3(d). | In accordance with the provisions of the Akero Therapeutics, Inc. 2019 Employee Stock Purchase Plan, these shares were purchased at 85% of the closing price of the Issuer's common stock on January 2, 2025.
Filing Info
Gangloff Scott A.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-12-09 | AKRO | D | — |
| 2025-08-15 | AKRO | M | $51K |
| 2025-08-15 | AKRO | M | $0 |
| 2025-06-30 | AKRO | A | $7K |
| 2025-06-18 | AKRO | ▼ | $47K |
Other Insiders at AKRO (90d)
No other insider activity at this issuer in the last 90 days.